Search

everythinglearnresearchcommunity

for

Search:↓

More adolescent girls in urban areas of India have Polycystic Ovary Syndrome compared to those in rural areas.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Iraqi women with PCOS often have higher testosterone levels and obesity.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Finasteride reduces testosterone conversion, progesterone lessens this, and levamisole enhances finasteride's effect.

Integrating best practices for steroid users in Swiss primary care is feasible and beneficial, but doping laws need change.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

People with polycystic ovary syndrome (PCOS) are more likely to have higher levels of depression and anxiety, but their personality traits are similar to those without PCOS.